COVID-19: PathoQuest Services ContinuityMore than ever, we remain by your side to improve the safety of your biologics and accelerate their time-to-market. Learn more Learn More Learn more “Greater pathogen detection for better decisions” Clinical Diagnostics Biologics Genomic Service What’s NewPathoQuest receives PM’up Relance Industrie Île-de-France grant to expand biologic testing capabilities at Paris site25 November 2020Charles River and PathoQuest Strengthen Strategic Partnership12 November 2020COVID-19: PathoQuest services continuity update6 November 2020PathoQuest to participate in next BioPharma Asia webinar: VIRAL SAFETY BY DESIGN FOR CELL AND GENE THERAPY PRODUCTS8 October 2020
